In human cancer, RNCR3 as an oncogene promotes the progression of malignant tumors such as colorectal cancer, glioma, and prostate cancer [12–14]; however, the biological function and molecular mechanism of RNCR3 in HCC have not been fully elucidated. This evidence concerns the gene MIR124-1HG and central nervous system cancer.